Dr. Jeffrey Melson-Clarke
Overview
I realized during a biology class in college that I could use my interest in science to help make a difference in people’s lives. It drove my decision to pursue a career in medicine. I realized early in medical school that I wanted to spend my career trying to understand cancer, how to fight it and caring for patients who have it. As a medical oncologist with Duke Cancer Center, I specialize in cancers of the chest, including lung cancer and mesothelioma. Working closely with my patients, getting to know them personally and understanding their values and goals, allows me to develop individualized care and treatment plans for each one. The most rewarding part of my work is developing long term relationships with my patients and their families throughout their cancer journeys. I am motivated and inspired by how my patients live their lives everyday.
Dr. Melson-Clarke is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Large-Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), and Non-Small Cell Lung Cancer (NSCLC).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
20 Duke Medicine Cir, Durham, NC 27710
6301 Herndon Rd, Durham, NC 27713
Additional Areas of Focus
Dr. Melson-Clarke has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
James Vredenburgh is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Vredenburgh is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Glioma, Glioblastoma, Astrocytoma, Brain Tumor, and Bone Marrow Aspiration.
Duke Cancer Center
I am a medical oncologist who specializes in the treatment of patients with skin cancer. I am part of a team of surgical oncologists, dermatologists, and radiation oncologists who all work together to determine the best treatment approach for each patient. My focus is on treating patients with advanced melanoma, as well as melanoma that is at high risk for recurrence after surgery. We also treat patients with merkel cell carcinoma and advanced basal cell and cutaneous squamous cell carcinoma. We also have a number of clinical trial options available, allowing our patients access to the newest therapies available. Dr. Salama is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Melanoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Posterior Fossa Tumor.
University Of North Carolina At Chapel Hill
Frances Collichio is a Hematologist and an Oncologist in Chapel Hill, North Carolina. Dr. Collichio is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Melanoma, Astrocytoma, Glioblastoma, and Oligodendroglioma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Melson-Clarke isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Melson-Clarke isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Melson-Clarke isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Melson-Clarke isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Melson-Clarke isDistinguished. Learn about Lung Cancer.
- MesotheliomaDr. Melson-Clarke isDistinguished. Learn about Mesothelioma.
- Advanced
- Metastatic Brain TumorDr. Melson-Clarke isAdvanced. Learn about Metastatic Brain Tumor.
- Metastatic Pleural TumorDr. Melson-Clarke isAdvanced. Learn about Metastatic Pleural Tumor.
- Posterior Fossa TumorDr. Melson-Clarke isAdvanced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)Dr. Melson-Clarke isAdvanced. Learn about Primitive Neuroectodermal Tumor (PNET).
- Experienced
- Lung NodulesDr. Melson-Clarke isExperienced. Learn about Lung Nodules.
- Lymphofollicular HyperplasiaDr. Melson-Clarke isExperienced. Learn about Lymphofollicular Hyperplasia.
- Neuroendocrine TumorDr. Melson-Clarke isExperienced. Learn about Neuroendocrine Tumor.
- Thymic Epithelial TumorDr. Melson-Clarke isExperienced. Learn about Thymic Epithelial Tumor.